1	AstraZeneca	astrazeneca	NNP	p2=NNS	4	nsubj	4:A0=PAG
2	on	on	IN	_	1	prep	_
3	Monday	monday	NNP	_	2	pobj	_
4	rejected	reject	VBD	pb=reject.01	0	root	_
5	Pfizer	pfizer	NNP	_	12	poss	_
6	's	's	POS	_	5	possessive	_
7	"	"	``	_	12	punct	_
8	final	final	JJ	_	9	amod	_
9	proposal	proposal	NN	_	12	nn	_
10	"	"	''	_	12	punct	_
11	buyout	buyout	NN	p2=VBD	12	nn	_
12	offer	offer	NN	p2=VBP	4	dobj	4:A1=PPT
13	of	of	IN	_	12	prep	_
14	$	$	$	_	16	quantmod	_
15	117	0	CD	_	16	number	_
16	billion	#crd#	CD	_	13	pobj	_
17	.	.	.	_	4	punct	_

1	Shares	share	NNS	_	7	nsubj	7:A1=LOC
2	of	of	IN	_	1	prep	_
3	the	the	DT	_	6	det	_
4	British	british	JJ	_	6	amod	_
5	drug	drug	NN	_	6	nn	_
6	giant	giant	NN	p2=JJ	2	pobj	_
7	dived	dive	VBN	p2=VBD|pb=dive.01	0	root	_
8	as	as	IN	_	10	mark	_
9	investors	investor	NNS	_	10	nsubj	12:A0=PAG;10:A1=PPT
10	seemed	seem	VBD	pb=seem.01	7	advcl	7:AM-TMP
11	to	to	TO	_	12	aux	_
12	lose	lose	VB	pb=lose.02	10	xcomp	10:C-A1
13	hope	hope	NN	p2=VB	12	dobj	12:A1=PPT
14	that	that	IN	_	21	complm	_
15	the	the	DT	_	16	det	_
16	merger	merger	NN	_	21	nsubj	21:A1=PPT
17	of	of	IN	_	16	prep	_
18	titans	titan	NNS	_	17	pobj	_
19	would	would	MD	_	21	aux	21:AM-MOD
20	ever	ever	RB	_	21	advmod	21:AM-TMP
21	take	take	VB	pb=take.14	13	ccomp	_
22	place	place	NN	_	21	dobj	21:A2
23	.	.	.	_	7	punct	_

1	Pfizer	pfizer	NNP	p2=NN	6	nsubj	6:A0
2	(	(	-LRB-	_	1	punct	_
3	PFE	pfe	NNP	_	1	appos	_
4	)	)	-RRB-	_	1	punct	_
5	first	#ord#	RB	p2=JJ	6	advmod	6:AM-TMP
6	revealed	reveal	VBD	p2=VBN|pb=reveal.01	0	root	_
7	on	on	IN	_	6	prep	6:AM-TMP
8	April	april	NNP	_	7	pobj	_
9	28	0	CD	_	8	num	_
10	that	that	IN	p2=WDT	16	complm	_
11	AstraZeneca	astrazeneca	NNP	_	16	nsubj	16:A0=PAG
12	(	(	-LRB-	_	13	punct	_
13	AZN	azn	NNP	_	11	appos	_
14	)	)	-RRB-	_	13	punct	_
15	had	have	VBD	_	16	aux	_
16	rejected	reject	VBN	pb=reject.01	6	ccomp	6:A1=PPT
17	a	a	DT	_	18	det	_
18	proposal	proposal	NN	_	16	dobj	16:A1=PPT
19	early	early	RB	_	21	advmod	_
20	this	this	DT	_	21	det	_
21	year	year	NN	_	16	npadvmod	16:AM-TMP
22	,	,	,	_	16	punct	_
23	and	and	CC	_	16	cc	_
24	a	a	DT	_	26	det	_
25	few	few	JJ	_	26	amod	_
26	days	day	NNS	_	27	npadvmod	_
27	later	later	RB	p2=RBR	28	advmod	28:AM-TMP
28	made	make	VBD	p2=VBP|pb=make.01	16	conj	_
29	a	a	DT	_	31	det	_
30	higher	high	JJR	_	31	amod	_
31	bid	bid	NN	_	28	dobj	28:AM-PRR
32	of	of	IN	_	31	prep	_
33	50	0	CD	_	35	num	_
34	British	british	JJ	_	35	amod	_
35	pounds	pound	NNS	_	32	pobj	_
36	per	per	IN	_	35	prep	_
37	share	share	NN	_	36	pobj	_
38	,	,	,	_	35	punct	_
39	or	or	CC	_	35	cc	_
40	about	about	RB	p2=IN	43	advmod	_
41	$	$	$	_	43	quantmod	_
42	106	0	CD	_	43	number	_
43	billion	#crd#	CD	_	35	conj	_
44	.	.	.	_	6	punct	_

1	AstraZeneca	astrazeneca	NNP	_	2	nsubj	2:A0=PAG;7:A0
2	turned	turn	VBD	pb=turn.12	0	root	_
3	Pfizer	pfizer	NNP	_	2	dobj	2:A1=PPT
4	down	down	RP	p2=RB	2	prt	2:C-V
5	again	again	RB	_	2	advmod	2:AM-TMP
6	,	,	,	_	2	punct	_
7	saying	say	VBG	pb=say.01	2	advcl	2:AM-ADV
8	the	the	DT	_	9	det	_
9	price	price	NN	_	10	nsubj	10:A1=PPT
10	was	be	VBD	pb=be.01	7	ccomp	7:A1=PPT
11	too	too	RB	_	12	advmod	_
12	low	low	JJ	_	10	acomp	10:A2=PRD
13	and	and	CC	_	10	cc	_
14	that	that	IN	_	17	mark	_
15	the	the	DT	_	16	det	_
16	offer	offer	NN	_	17	nsubj	17:A0
17	contained	contain	VBD	pb=contain.01	10	conj	_
18	too	too	RB	_	19	advmod	_
19	much	much	JJ	_	20	amod	_
20	stock	stock	NN	_	17	dobj	17:A1
21	,	,	,	_	17	punct	_
22	at	at	IN	_	17	prep	_
23	67	0	CD	_	24	num	_
24	%	%	NN	_	22	pobj	_
25	.	.	.	_	2	punct	_

1	Both	both	DT	p2=CC	2	det	_
2	AstraZeneca	astrazeneca	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	management	management	NN	_	8	nsubj	8:A1=PPT
5	and	and	CC	_	4	cc	_
6	many	many	JJ	_	7	amod	_
7	Brits	brit	NNPS	_	4	conj	_
8	were	be	VBD	pb=be.01	0	root	_
9	also	also	RB	_	8	advmod	8:AM-ADV
10	worried	worried	JJ	p2=VBN	8	acomp	8:A2=PRD
11	,	,	,	_	10	punct	_
12	based	base	VBN	_	10	prep	_
13	on	on	IN	_	12	prep	_
14	some	some	DT	_	13	pobj	_
15	of	of	IN	_	14	prep	_
16	Pfizer	pfizer	NNP	p2=NN	19	poss	_
17	's	's	POS	_	16	possessive	_
18	past	past	JJ	_	19	amod	_
19	acquisitions	acquisition	NNS	_	15	pobj	_
20	,	,	,	_	14	punct	_
21	that	that	IN	_	24	complm	_
22	it	it	PRP	_	24	nsubj	26:A0=PAG
23	was	be	VBD	_	24	aux	_
24	going	go	VBG	pb=go.04	14	rcmod	_
25	to	to	TO	_	26	aux	_
26	slash	slash	VB	pb=slash.02	24	xcomp	_
27	British	british	JJ	_	31	amod	_
28	research	research	NN	_	31	nn	_
29	and	and	CC	_	28	cc	_
30	development	development	NN	_	28	conj	_
31	staff	staff	NN	_	26	dobj	26:A1=PPT
32	after	after	IN	_	26	prep	26:AM-TMP
33	gaining	gain	VBG	pb=gain.02	32	pcomp	_
34	the	the	DT	_	36	det	_
35	tax	tax	NN	_	36	nn	_
36	benefits	benefit	NNS	_	33	dobj	33:A1=PPT
37	of	of	IN	_	36	prep	_
38	a	a	DT	_	39	det	_
39	move	move	NN	_	37	pobj	_
40	across	across	IN	_	39	prep	_
41	the	the	DT	_	42	det	_
42	Atlantic	atlantic	NNP	_	40	pobj	_
43	.	.	.	_	8	punct	_

1	Pfizer	pfizer	NNP	p2=NN	4	nn	_
2	CEO	ceo	NNP	p2=NN	4	nn	_
3	Ian	ian	NNP	_	4	nn	_
4	Read	read	NNP	_	5	nsubj	5:A0=PAG
5	made	make	VBD	pb=make.01	0	root	_
6	a	a	DT	_	7	det	_
7	series	series	NN	_	5	dobj	5:A1=PRD
8	of	of	IN	_	7	prep	_
9	pledges	pledge	NNS	_	8	pobj	_
10	to	to	IN	_	9	prep	_
11	the	the	DT	_	13	det	_
12	U.K.	u.k.	NNP	p2=JJ	13	nn	_
13	government	government	NN	_	10	pobj	_
14	to	to	TO	_	15	aux	_
15	preserve	preserve	VB	pb=preserve.01	9	infmod	_
16	certain	certain	JJ	_	17	amod	_
17	jobs	job	NNS	_	15	dobj	15:A1=PPT
18	and	and	CC	_	17	cc	_
19	resources	resource	NNS	_	17	conj	_
20	in	in	IN	_	15	prep	15:AM-LOC
21	Britain	britain	NNP	_	20	pobj	_
22	.	.	.	_	5	punct	_

1	On	on	IN	_	18	prep	18:AM-LOC
2	the	the	DT	_	4	det	_
3	other	other	JJ	_	4	amod	_
4	side	side	NN	_	1	pobj	_
5	of	of	IN	_	4	prep	_
6	the	the	DT	_	7	det	_
7	pond	pond	NN	_	5	pobj	_
8	,	,	,	_	18	punct	_
9	President	president	NNP	_	10	nn	_
10	Obama	obama	NNP	_	18	nsubj	18:A0=PAG
11	and	and	CC	_	10	cc	_
12	other	other	JJ	_	15	amod	_
13	U.S.	u.s.	NNP	_	15	nn	_
14	political	political	JJ	_	15	amod	_
15	leaders	leader	NNS	_	10	conj	_
16	have	have	VBP	_	18	aux	_
17	been	be	VBN	_	18	aux	_
18	pushing	push	VBG	pb=push.01	0	root	_
19	legislation	legislation	NN	_	18	dobj	18:A1=PPT
20	against	against	IN	_	19	prep	_
21	the	the	DT	_	22	det	_
22	sort	sort	NN	_	20	pobj	31:A1
23	of	of	IN	_	22	prep	_
24	tax	tax	NN	_	26	hmod	_
25	-	-	HYPH	_	26	hyph	_
26	inversion	inversion	NN	_	27	nn	_
27	acquisitions	acquisition	NNS	_	23	pobj	_
28	that	that	WDT	p2=IN	31	dobj	31:R-A1
29	Pfizer	pfizer	NNP	_	31	nsubj	31:A0=PAG;33:A0=PAG
30	is	be	VBZ	_	31	aux	_
31	attempting	attempt	VBG	pb=attempt.01	22	rcmod	_
32	-	-	:	p2=,	31	punct	_
33	buying	buy	VBG	pb=buy.01	31	xcomp	_
34	a	a	DT	_	35	det	_
35	firm	firm	NN	_	33	dobj	33:A1=PPT
36	in	in	IN	_	33	prep	_
37	a	a	DT	_	42	det	_
38	lower	low	JJR	p2=RBR	40	hmod	_
39	-	-	HYPH	_	40	hyph	_
40	tax	tax	NN	_	42	nn	_
41	foreign	foreign	JJ	_	42	amod	_
42	country	country	NN	_	36	pobj	_
43	to	to	TO	_	44	aux	_
44	get	get	VB	pb=get.01	33	advcl	_
45	an	an	DT	_	47	det	_
46	official	official	JJ	p2=NN	47	amod	_
47	domicile	domicile	NN	p2=JJ	44	dobj	44:A1=PPT
48	there	there	RB	_	44	advmod	44:A2=DIR
49	.	.	.	_	18	punct	_

1	Several	several	JJ	_	4	amod	_
2	specialty	specialty	NN	_	4	nn	_
3	drug	drug	NN	_	4	nn	_
4	takeovers	takeover	NNS	_	6	nsubj	6:A2=PPT
5	have	have	VBP	_	6	aux	_
6	involved	involve	VBN	pb=involve.01	0	root	_
7	U.S.	u.s.	NNP	_	8	nn	_
8	companies	company	NNS	_	6	dobj	9:A0;6:A1=PPT
9	redomiciling	redomiciling	VBG	pb=redomiciling.01	8	partmod	_
10	in	in	IN	_	9	prep	9:AM-LOC
11	even	even	RB	_	13	hmod	_
12	-	-	HYPH	p2=:	13	hyph	_
13	lower	low	JJR	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	tax	tax	NN	_	16	nn	_
16	Ireland	ireland	NNP	p2=NN	10	pobj	_
17	.	.	.	_	6	punct	_

1	Under	under	IN	_	6	prep	6:AM-LOC
2	British	british	JJ	_	3	amod	_
3	law	law	NN	_	1	pobj	_
4	,	,	,	_	6	punct	_
5	Pfizer	pfizer	NNP	_	6	nsubj	6:A0=PAG;11:A0=PAG
6	had	have	VBD	pb=have.03	0	root	_
7	until	until	IN	_	6	prep	6:AM-TMP
8	May	may	NNP	_	7	pobj	_
9	26	0	CD	_	8	num	_
10	to	to	TO	_	11	aux	_
11	make	make	VB	pb=make.02	6	advcl	6:AM-PRP
12	another	another	DT	_	13	det	_
13	bid	bid	NN	_	11	dobj	11:AM-PRR
14	,	,	,	_	6	punct	_
15	after	after	IN	_	20	prep	20:R-AM-TMP
16	which	which	WDT	_	15	pobj	_
17	it	it	PRP	_	20	nsubj	20:A0=PAG
18	could	could	MD	_	20	aux	20:AM-MOD
19	n't	not	RB	_	20	neg	20:AM-NEG
20	make	make	VB	pb=make.02	6	advcl	_
21	another	another	DT	_	22	det	_
22	one	#crd#	NN	p2=CD	20	dobj	20:A1=PRD
23	for	for	IN	_	20	prep	_
24	six	#crd#	CD	_	25	num	_
25	months	month	NNS	_	23	pobj	_
26	unless	unless	IN	p2=JJ	28	mark	_
27	AstraZeneca	astrazeneca	NNP	_	28	nsubj	28:A0=PAG;30:A0=PAG
28	agreed	agree	VBD	pb=agree.01	20	advcl	_
29	to	to	TO	_	30	aux	_
30	negotiate	negotiate	VB	pb=negotiate.01	28	xcomp	28:A1=PPT
31	.	.	.	_	6	punct	_

1	On	on	IN	_	5	prep	5:AM-TMP
2	Sunday	sunday	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	Pfizer	pfizer	NNP	_	5	nsubj	5:A0=PAG
5	announced	announce	VBD	pb=announce.01	24	ccomp	_
6	that	that	IN	_	16	complm	_
7	an	an	DT	_	8	det	_
8	offer	offer	NN	_	16	nsubjpass	16:A1=PPT
9	of	of	IN	_	8	prep	_
10	53.50	0	CD	_	11	num	_
11	pounds	pound	NNS	_	9	pobj	_
12	a	a	DT	_	13	det	_
13	share	share	NN	_	11	npadvmod	_
14	had	have	VBD	_	16	aux	_
15	been	be	VBN	_	16	auxpass	_
16	rejected	reject	VBN	pb=reject.01	5	ccomp	5:A1=PPT
17	the	the	DT	_	19	det	_
18	previous	previous	JJ	_	19	amod	_
19	Friday	friday	NNP	_	16	npadvmod	16:AM-TMP
20	,	,	,	_	24	punct	_
21	so	so	RB	p2=CC	24	advmod	_
22	the	the	DT	_	23	det	_
23	company	company	NN	_	24	nsubj	24:A0=PAG
24	made	make	VBD	pb=make.02	0	root	_
25	its	its	PRP$	_	28	poss	_
26	"	"	``	_	28	punct	_
27	final	final	JJ	_	28	amod	_
28	proposal	proposal	NN	_	24	dobj	24:AM-PRR
29	"	"	''	_	28	punct	_
30	at	at	IN	_	24	prep	_
31	55	0	CD	_	32	num	_
32	pounds	pound	NNS	_	30	pobj	_
33	,	,	,	_	32	punct	_
34	45	0	CD	_	35	num	_
35	%	%	NN	_	32	appos	_
36	of	of	IN	_	35	prep	_
37	it	it	PRP	_	36	pobj	_
38	cash	cash	NN	p2=VBP	24	ccomp	_
39	.	.	.	_	24	punct	_

1	On	on	IN	_	5	prep	5:AM-TMP
2	Monday	monday	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0;10:A0
5	said	say	VBD	pb=say.01	0	root	_
6	no	no	UH	p2=DT	8	intj	_
7	yet	yet	RB	p2=CC	8	advmod	_
8	again	again	RB	_	5	advmod	5:AM-TMP
9	,	,	,	_	5	punct	_
10	saying	say	VBG	pb=say.01	5	advcl	5:AM-ADV
11	that	that	IN	_	16	complm	_
12	Pfizer	pfizer	NNP	_	15	poss	_
13	's	's	POS	_	12	possessive	_
14	new	new	JJ	_	15	amod	_
15	offer	offer	NN	_	16	nsubj	16:A1=PPT
16	is	be	VBZ	pb=be.01	10	ccomp	10:A1=PPT
17	about	about	RB	p2=IN	18	advmod	_
18	10	0	CD	_	19	num	_
19	%	%	NN	_	21	nsubj	_
20	too	too	RB	_	21	advmod	_
21	low	low	JJ	p2=RB	16	acomp	16:A2=PRD
22	.	.	.	_	5	punct	_

1	Pfizer	pfizer	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	that	that	IN	_	7	complm	_
4	it	it	PRP	_	7	nsubj	10:A0=PAG;7:A1=PPT
5	wo	wo	MD	_	7	aux	7:AM-MOD
6	n't	not	RB	_	7	neg	7:AM-NEG
7	go	go	VB	pb=go.08	2	ccomp	2:A1=PPT
8	hostile	hostile	JJ	_	7	acomp	7:A2=PRD
9	,	,	,	_	7	punct	_
10	leading	lead	VBG	pb=lead.01	7	advcl	7:AM-ADV
11	to	to	IN	_	10	prep	10:A4=GOL
12	much	much	JJ	_	13	amod	_
13	discussion	discussion	NN	_	11	pobj	_
14	on	on	IN	_	13	prep	_
15	Wall	wall	NNP	_	16	nn	_
16	Street	street	NNP	_	14	pobj	_
17	as	as	IN	_	10	prep	_
18	to	to	IN	_	17	prep	_
19	whether	whether	IN	_	25	mark	_
20	AstraZeneca	astrazeneca	NNP	_	23	poss	_
21	's	's	POS	_	20	possessive	_
22	cold	cold	JJ	_	23	amod	_
23	shoulder	shoulder	NN	_	25	nsubj	25:A0=PAG
24	finally	finally	RB	_	25	advmod	25:AM-TMP
25	kills	kill	VBZ	pb=kill.01	18	pcomp	_
26	its	its	PRP$	_	27	poss	_
27	hopes	hope	NNS	_	25	dobj	25:A1=PPT
28	.	.	.	_	2	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=JJ	2	nn	_
2	shares	share	NNS	_	3	nsubj	3:A1=PPT
3	fell	fall	VBD	pb=fall.01	0	root	_
4	12	0	CD	_	5	num	_
5	%	%	NN	_	3	npadvmod	3:A2=EXT
6	to	to	IN	_	3	prep	3:A4=GOL
7	70.63	0	CD	_	6	pobj	_
8	,	,	,	_	3	punct	_
9	giving	give	VBG	pb=give.01	3	advcl	3:AM-ADV
10	up	up	RP	_	9	prt	9:C-V
11	much	much	JJ	_	9	dobj	9:A1=PPT
12	of	of	IN	_	11	prep	_
13	its	its	PRP$	_	15	poss	_
14	recent	recent	JJ	_	15	amod	_
15	gains	gain	NNS	_	12	pobj	_
16	on	on	IN	_	15	prep	_
17	takeover	takeover	NN	_	18	nn	_
18	talks	talk	NNS	_	16	pobj	_
19	.	.	.	_	3	punct	_

1	Morningstar	morningstar	NN	p2=JJR	2	nn	_
2	analyst	analyst	NN	_	4	nn	_
3	Damien	damien	NNP	_	4	nn	_
4	Conover	conover	NNP	_	5	nsubj	5:A0=PAG
5	wrote	write	VBD	pb=write.01	0	root	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	a	a	DT	_	9	det	_
8	research	research	NN	_	9	nn	_
9	note	note	NN	_	6	pobj	_
10	Monday	monday	NNP	_	5	npadvmod	5:AM-TMP
11	that	that	IN	p2=WDT	17	complm	_
12	the	the	DT	_	13	det	_
13	odds	odds	NNS	_	17	nsubj	17:A1=PPT
14	of	of	IN	_	13	prep	_
15	a	a	DT	_	16	det	_
16	deal	deal	NN	_	14	pobj	_
17	are	be	VBP	pb=be.01	5	ccomp	5:A1=PPT
18	now	now	RB	_	17	advmod	17:AM-TMP
19	well	well	RB	_	20	advmod	_
20	below	below	IN	_	17	prep	17:A2=PRD
21	50	0	CD	_	22	num	_
22	%	%	NN	_	20	pobj	_
23	.	.	.	_	5	punct	_

1	"	"	``	_	3	punct	_
2	We	we	PRP	_	3	nsubj	3:A1=PPT
3	are	be	VBP	pb=be.01	45	ccomp	45:A1=PPT
4	surprised	surprised	JJ	p2=VBN	3	acomp	3:A2=PRD
5	by	by	IN	_	4	prep	_
6	Astra	astra	NNP	_	8	poss	_
7	's	's	POS	_	6	possessive	_
8	rejection	rejection	NN	_	5	pobj	_
9	,	,	,	_	3	punct	_
10	as	as	IN	_	12	mark	_
11	we	we	PRP	_	12	nsubj	12:A0=PAG
12	believe	believe	VBP	pb=believe.01	3	advcl	3:AM-CAU
13	the	the	DT	_	14	det	_
14	offer	offer	NN	_	17	nsubj	17:A0=PAG;26:A0=PAG
15	not	not	RB	_	17	preconj	_
16	only	only	RB	p2=JJ	15	advmod	_
17	rewards	reward	VBZ	p2=NNS|pb=reward.01	12	ccomp	12:A1=PPT
18	Astra	astra	NNP	p2=NN	17	dobj	17:A1=PPT
19	for	for	IN	_	17	prep	17:A2=CAU
20	its	its	PRP$	_	22	poss	_
21	current	current	JJ	p2=NN	22	amod	_
22	valuation	valuation	NN	_	19	pobj	_
23	,	,	,	_	17	punct	_
24	but	but	CC	_	17	cc	_
25	also	also	RB	_	26	advmod	26:AM-ADV
26	gives	give	VBZ	pb=give.01	17	conj	_
27	Astra	astra	NNP	p2=NN	26	iobj	26:A2=GOL
28	shareholders	shareholder	NNS	p2=VBZ	26	iobj	_
29	a	a	DT	_	30	det	_
30	majority	majority	NN	_	26	dobj	26:A1=PPT
31	of	of	IN	_	30	prep	_
32	the	the	DT	_	33	det	_
33	benefits	benefit	NNS	_	31	pobj	_
34	from	from	IN	_	33	prep	_
35	the	the	DT	_	41	det	_
36	expected	expect	VBN	p2=JJ|pb=expect.01	41	amod	_
37	merger	merger	NN	_	39	hmod	_
38	-	-	HYPH	_	39	hyph	_
39	related	relate	VBN	_	41	amod	_
40	cost	cost	NN	p2=JJ	41	nn	_
41	savings	saving	NNS	_	34	pobj	36:A1=PPT
42	,	,	,	_	45	punct	_
43	"	"	''	_	45	punct	_
44	he	he	PRP	_	45	nsubj	45:A0=PAG
45	wrote	write	VBD	pb=write.01	0	root	_
46	.	.	.	_	45	punct	_

1	"	"	``	p2=''	14	punct	_
2	While	while	IN	p2=NNP	4	mark	_
3	Astra	astra	NNP	_	4	nsubj	4:A0=PAG;9:A0=PAG
4	has	have	VBZ	pb=have.03	14	advcl	14:AM-ADV
5	until	until	IN	_	4	prep	4:AM-TMP
6	May	may	NNP	_	5	pobj	_
7	26	0	CD	_	6	num	_
8	to	to	TO	p2=IN	9	aux	_
9	engage	engage	VB	pb=engage.01	4	xcomp	_
10	with	with	IN	_	9	prep	9:A2=PPT
11	Pfizer	pfizer	NNP	_	10	pobj	_
12	,	,	,	_	14	punct	_
13	we	we	PRP	_	14	nsubj	14:A0=PAG
14	believe	believe	VBP	pb=believe.01	0	root	_
15	its	its	PRP$	_	16	poss	_
16	disagreement	disagreement	NN	_	19	nsubj	22:A0=PAG;19:A1=PPT
17	on	on	IN	_	16	prep	_
18	valuation	valuation	NN	p2=NNP	17	pobj	_
19	is	be	VBZ	pb=be.01	14	ccomp	14:A1=PPT
20	likely	likely	JJ	_	19	acomp	19:A2=PRD
21	to	to	TO	_	22	aux	_
22	derail	derail	VB	pb=derail.01	20	xcomp	_
23	the	the	DT	_	24	det	_
24	merger	merger	NN	_	22	dobj	22:A1=PPT
25	.	.	.	_	14	punct	_

1	Analyst	analyst	NNP	p2=NN	3	nn	_
2	Mark	mark	NNP	_	3	nn	_
3	Schoenebaum	schoenebaum	NNP	_	8	nsubj	8:A0=PAG
4	of	of	IN	_	3	prep	_
5	ISI	isi	NNP	_	6	nn	_
6	Group	group	NNP	_	4	pobj	_
7	still	still	RB	_	8	advmod	8:AM-TMP
8	held	hold	VBD	pb=hold.01	0	root	_
9	out	out	RP	p2=RB	8	prt	8:C-V
10	some	some	DT	_	11	det	_
11	hope	hope	NN	p2=VBP	8	dobj	8:A1=PPT
12	that	that	IN	p2=WDT	16	complm	_
13	shareholder	shareholder	NN	_	14	nn	_
14	pressure	pressure	NN	_	16	nsubj	16:A0=PAG
15	would	would	MD	_	16	aux	16:AM-MOD
16	drive	drive	VB	pb=drive.02	11	ccomp	_
17	AstraZeneca	astrazeneca	NNP	_	16	dobj	16:A1=PPT
18	back	back	RB	_	16	advmod	16:A2=PRD
19	to	to	IN	_	18	prep	_
20	the	the	DT	_	22	det	_
21	bargaining	bargaining	NN	_	22	nn	_
22	table	table	NN	_	19	pobj	_
23	.	.	.	_	8	punct	_
24	"	"	''	_	8	punct	_

1	Our	our	PRP$	_	4	poss	_
2	risk	risk	NN	_	3	nn	_
3	arb	arb	NN	p2=VBP	4	nn	_
4	desk	desk	NN	_	5	nsubj	5:A0=PAG
5	notes	note	VBZ	p2=NNS|pb=note.01	78	ccomp	78:A1=PPT
6	that	that	IN	p2=DT	12	complm	_
7	:	:	:	_	12	punct	_
8	(	(	-LRB-	_	9	punct	_
9	1	0	LS	p2=CD	12	meta	_
10	)	)	-RRB-	_	9	punct	_
11	AZN	azn	NNP	p2=VB	12	nsubj	12:A0=PAG
12	dropped	drop	VBD	pb=drop.05	5	ccomp	5:A1=PPT
13	the	the	DT	_	14	det	_
14	words	word	NNS	_	12	dobj	12:A1=PPT
15	'	'	``	p2=POS	16	punct	_
16	significantly	significantly	RB	_	12	advmod	_
17	'	'	''	_	12	punct	_
18	and	and	CC	_	12	cc	_
19	'	'	``	_	20	punct	_
20	substantial	substantial	JJ	_	12	conj	_
21	'	'	''	_	20	punct	_
22	from	from	IN	_	20	prep	_
23	the	the	DT	_	26	det	_
24	'	'	``	p2=''	26	punct	_
25	significantly	significantly	RB	_	26	amod	_
26	undervalues	undervalues	NNS	p2=VBZ	22	pobj	_
27	'	'	''	_	26	punct	_
28	and	and	CC	_	26	cc	_
29	'	'	``	_	31	punct	_
30	substantial	substantial	JJ	_	31	amod	_
31	shortfall	shortfall	NN	_	26	conj	_
32	'	'	''	_	31	punct	_
33	language	language	NN	p2=VB	31	appos	_
34	the	the	DT	_	35	det	_
35	company	company	NN	_	31	appos	36:A1=PPT
36	used	use	VBN	p2=VBD|pb=use.01	35	partmod	_
37	in	in	IN	_	36	prep	36:AM-LOC
38	the	the	DT	_	40	det	_
39	prior	prior	JJ	p2=NN	40	amod	_
40	rejections	rejection	NNS	_	37	pobj	_
41	including	include	VBG	_	40	prep	_
42	the	the	DT	_	45	det	_
43	GBP	gbp	NNP	p2=$	45	nn	_
44	53.50	0	CD	_	45	num	_
45	proposal	proposal	NN	_	41	pobj	_
46	on	on	IN	_	45	prep	_
47	Friday	friday	NNP	_	46	pobj	_
48	;	;	,	p2=:	12	punct	_
49	and	and	CC	_	12	cc	_
50	(	(	-LRB-	_	51	punct	_
51	2	0	LS	_	60	meta	_
52	)	)	-RRB-	_	51	punct	_
53	the	the	DT	_	54	det	_
54	word	word	NN	_	60	nsubjpass	60:A1
55	'	'	``	p2=''	54	punct	_
56	unanimous	unanimous	JJ	_	54	appos	_
57	'	'	''	_	54	punct	_
58	is	be	VBZ	_	60	auxpass	_
59	not	not	RB	_	60	neg	60:AM-NEG
60	contained	contain	VBN	pb=contain.01	12	conj	_
61	in	in	IN	_	60	prep	60:A0
62	AZN	azn	NNP	_	64	poss	_
63	's	's	POS	_	62	possessive	_
64	description	description	NN	_	61	pobj	_
65	of	of	IN	_	64	prep	_
66	the	the	DT	_	67	det	_
67	BoD	bod	NNP	_	65	pobj	_
68	(	(	-LRB-	_	67	punct	_
69	board	board	NN	_	67	appos	_
70	of	of	IN	_	69	prep	_
71	directors	director	NNS	_	74	poss	_
72	'	'	POS	p2=''	71	possessive	_
73	)	)	-RRB-	_	74	punct	_
74	rejection	rejection	NN	_	70	pobj	_
75	,	,	,	_	78	punct	_
76	"	"	''	p2=``	78	punct	_
77	Schoenebaum	schoenebaum	NNP	_	78	nsubj	78:A0=PAG
78	wrote	write	VBD	pb=write.01	0	root	_
79	in	in	IN	_	78	prep	78:AM-LOC
80	an	an	DT	_	81	det	_
81	email	email	NN	_	79	pobj	_
82	to	to	IN	_	78	prep	78:A2=GOL
83	clients	client	NNS	_	82	pobj	_
84	Monday	monday	NNP	_	78	npadvmod	78:AM-TMP
85	.	.	.	_	78	punct	_
86	"	"	''	_	78	punct	_

1	Our	our	PRP$	_	2	poss	_
2	desk	desk	NN	_	3	nsubj	3:A0=PAG
3	believes	believe	VBZ	pb=believe.01	0	root	_
4	it	it	PRP	_	5	nsubj	5:A1=PPT
5	's	be	VBZ	pb=be.01	3	ccomp	3:A1=PPT
6	now	now	RB	_	5	advmod	5:AM-TMP
7	in	in	IN	_	3	prep	3:AM-MNR
8	AZN	azn	NNP	p2=JJ	9	nn	_
9	shareholders	shareholder	NNS	_	11	poss	_
10	'	'	POS	_	9	possessive	_
11	hands	hand	NNS	_	7	pobj	_
12	and	and	CC	_	5	cc	_
13	that	that	IN	_	15	mark	_
14	this	this	DT	_	15	nsubj	15:A1=PPT
15	is	be	VBZ	pb=be.01	5	conj	_
16	effectively	effectively	RB	_	15	advmod	15:AM-ADV
17	a	a	DT	_	22	det	_
18	'	'	``	_	22	punct	_
19	hostile	hostile	JJ	_	22	amod	_
20	'	'	''	_	22	punct	_
21	tender	tender	NN	p2=JJ	22	nn	_
22	offer	offer	NN	_	15	attr	15:A2=PRD
23	.	.	.	_	3	punct	_

1	AstraZeneca	astrazeneca	NNP	_	4	nsubj	4:A0=PAG;7:A0=PAG
2	has	have	VBZ	_	4	aux	_
3	been	be	VBN	_	4	aux	_
4	working	work	VBG	pb=work.01	0	root	_
5	hard	hard	RB	_	4	advmod	4:AM-MNR
6	to	to	TO	_	7	aux	_
7	get	get	VB	pb=get.01	4	advcl	4:A1=PPT
8	shareholders	shareholder	NNS	_	9	nsubj	_
9	excited	excited	JJ	p2=VBN	7	ccomp	7:A1=PPT
10	about	about	IN	_	9	prep	_
11	its	its	PRP$	_	15	poss	_
12	long	long	JJ	_	14	hmod	_
13	-	-	HYPH	_	14	hyph	_
14	term	term	NN	_	15	nn	_
15	prospects	prospect	NNS	_	10	pobj	_
16	to	to	TO	_	17	aux	_
17	overcome	overcome	VB	pb=overcome.01	7	advcl	_
18	its	its	PRP$	_	21	poss	_
19	recent	recent	JJ	_	21	amod	_
20	weak	weak	JJ	p2=NN	21	amod	_
21	financials	financials	NNS	_	17	dobj	17:A1=PPT;24:A1=PPT
22	,	,	,	_	21	punct	_
23	which	which	WDT	_	24	nsubj	24:R-A1
24	are	be	VBP	pb=be.01	21	rcmod	_
25	due	due	JJ	_	24	acomp	24:A2=PRD
26	to	to	IN	p2=TO	25	prep	_
27	patent	patent	NN	p2=JJ	28	nn	_
28	losses	loss	NNS	_	26	pobj	_
29	and	and	CC	_	28	cc	_
30	soft	soft	JJ	_	32	amod	_
31	drug	drug	NN	_	32	nn	_
32	launches	launch	NNS	_	28	conj	_
33	.	.	.	_	4	punct	_

1	On	on	IN	_	7	prep	7:AM-TMP
2	May	may	NNP	_	1	pobj	_
3	7	0	CD	_	2	num	_
4	,	,	,	_	7	punct	_
5	the	the	DT	_	6	det	_
6	company	company	NN	_	7	nsubj	7:A0=PAG
7	set	set	VBD	pb=set.02	0	root	_
8	a	a	DT	_	10	det	_
9	revenue	revenue	NN	_	10	nn	_
10	target	target	NN	_	7	dobj	7:A1=PPT
11	of	of	IN	_	10	prep	_
12	$	$	$	_	14	quantmod	_
13	45	0	CD	_	14	number	_
14	billion	#crd#	CD	_	11	pobj	_
15	by	by	IN	_	7	prep	_
16	2023	0	CD	_	15	pobj	_
17	,	,	,	_	7	punct	_
18	nearly	nearly	RB	_	19	advmod	_
19	double	double	PDT	p2=VB	25	num	_
20	its	its	PRP$	_	25	poss	_
21	current	current	JJ	_	25	amod	_
22	12	0	CD	_	24	hmod	_
23	-	-	HYPH	_	24	hyph	_
24	month	month	NN	_	25	nn	_
25	sales	sale	NNS	_	7	dobj	_
26	.	.	.	_	7	punct	_

1	However	however	RB	_	5	advmod	5:AM-DIS
2	,	,	,	_	5	punct	_
3	it	it	PRP	_	5	nsubj	5:A0=PAG
4	also	also	RB	_	5	advmod	5:AM-ADV
5	admitted	admit	VBD	pb=admit.01	0	root	_
6	that	that	IN	_	12	complm	_
7	the	the	DT	_	8	det	_
8	growth	growth	NN	_	12	nsubj	14:A1=PPT
9	is	be	VBZ	_	12	aux	_
10	n't	not	RB	_	12	neg	12:AM-NEG
11	really	really	RB	_	12	advmod	12:AM-ADV
12	going	go	VBG	pb=go.04	5	ccomp	5:A1
13	to	to	TO	_	14	aux	_
14	start	start	VB	pb=start.01	12	xcomp	_
15	until	until	IN	_	14	prep	14:AM-TMP
16	2017	0	CD	_	15	pobj	_
17	.	.	.	_	5	punct	_

1	The	the	DT	_	3	det	_
2	general	general	JJ	_	3	amod	_
3	opinion	opinion	NN	_	7	nsubj	7:A1=PPT;9:A1=PPT
4	on	on	IN	_	3	prep	_
5	the	the	DT	_	6	det	_
6	Street	street	NNP	p2=NN	4	pobj	_
7	seems	seem	VBZ	pb=seem.01	0	root	_
8	to	to	TO	_	9	aux	_
9	be	be	VB	pb=be.01	7	xcomp	7:C-A1
10	that	that	IN	_	14	complm	_
11	the	the	DT	_	13	det	_
12	current	current	JJ	_	13	amod	_
13	offer	offer	NN	_	14	nsubj	14:A1=PPT
14	is	be	VBZ	pb=be.01	9	ccomp	9:A2=PRD
15	about	about	RB	p2=IN	17	advmod	_
16	as	as	RB	_	17	advmod	_
17	high	high	JJ	_	14	acomp	14:A2=PRD
18	as	as	IN	_	21	mark	_
19	Pfizer	pfizer	NNP	_	21	nsubj	21:A0=PPT;24:A0=PAG
20	can	can	MD	_	21	aux	21:AM-MOD;24:AM-MOD
21	go	go	VB	pb=go.02	14	advcl	_
22	and	and	CC	_	21	cc	_
23	still	still	RB	p2=VB	24	advmod	24:AM-TMP
24	get	get	VB	p2=VBP|pb=get.01	21	conj	_
25	a	a	DT	_	26	det	_
26	return	return	NN	_	24	dobj	24:A1=PPT
27	for	for	IN	_	26	prep	_
28	its	its	PRP$	_	30	poss	_
29	own	own	JJ	_	30	amod	_
30	shareholders	shareholder	NNS	_	27	pobj	_
31	.	.	.	_	7	punct	_

1	Deutsche	deutsche	NNP	_	2	nn	_
2	Bank	bank	NNP	_	3	nn	_
3	analyst	analyst	NN	_	5	nn	_
4	Mark	mark	NNP	_	5	nn	_
5	Clark	clark	NNP	_	6	nsubj	6:A0=PAG
6	wrote	write	VBD	pb=write.01	0	root	_
7	in	in	IN	_	6	prep	6:AM-TMP
8	early	early	JJ	_	9	amod	_
9	May	may	NNP	_	7	pobj	_
10	that	that	IN	_	15	complm	_
11	55	0	CD	_	12	num	_
12	pounds	pound	NNS	_	15	nsubj	15:A1=PPT
13	a	a	DT	_	14	det	_
14	share	share	NN	_	12	npadvmod	_
15	is	be	VBZ	pb=be.01	6	ccomp	6:A1=PPT
16	the	the	DT	_	18	det	_
17	appropriate	appropriate	JJ	_	18	amod	_
18	price	price	NN	_	15	attr	15:A2=PRD
19	.	.	.	_	6	punct	_

1	That	that	DT	_	2	det	_
2	opinion	opinion	NN	_	4	nsubjpass	4:A1=PPT
3	was	be	VBD	_	4	auxpass	_
4	shared	share	VBN	pb=share.01	0	root	_
5	by	by	IN	_	4	agent	4:A0=PAG
6	Leerink	leerink	NNP	_	9	poss	_
7	's	's	POS	_	6	possessive	_
8	Seamus	seamus	NNP	_	9	nn	_
9	Fernandez	fernandez	NNP	_	5	pobj	12:A0=PAG
10	,	,	,	_	9	punct	_
11	who	who	WP	_	12	nsubj	12:R-A0;15:R-A0
12	downgraded	downgrade	VBD	pb=downgrade.02	9	rcmod	_
13	AstraZeneca	astrazeneca	NNP	_	12	dobj	15:A0;12:A1=PPT
14	to	to	TO	_	15	aux	_
15	neutral	neutral	VB	p2=JJ|pb=neutral.01	12	xcomp	_
16	on	on	IN	_	15	prep	15:AM-TMP
17	Sunday	sunday	NNP	_	16	pobj	_
18	after	after	IN	_	20	mark	_
19	Pfizer	pfizer	NNP	_	20	nsubj	20:A0=PAG
20	announced	announce	VBD	pb=announce.01	12	advcl	12:AM-TMP;15:AM-TMP
21	its	its	PRP$	_	23	poss	_
22	final	final	JJ	_	23	amod	_
23	offer	offer	NN	_	20	dobj	20:A1=PPT
24	.	.	.	_	4	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG
2	wrote	write	VBD	pb=write.01	0	root	_
3	that	that	IN	_	13	complm	_
4	even	even	RB	_	5	advmod	_
5	in	in	IN	_	13	prep	13:AM-LOC
6	a	a	DT	_	8	det	_
7	bull	bull	NN	_	8	nn	_
8	scenario	scenario	NN	_	5	pobj	_
9	-	-	,	p2=HYPH	8	punct	_
10	in	in	IN	_	13	prep	_
11	which	which	WDT	_	10	pobj	_
12	AstraZeneca	astrazeneca	NNP	_	13	nsubj	13:A0=PAG
13	gets	get	VBZ	pb=get.01	2	ccomp	2:A1=PPT
14	seven	#crd#	CD	_	16	num	_
15	cancer	cancer	NN	_	16	nn	_
16	drugs	drug	NNS	_	17	nsubj	19:A0=PAG;17:A1=PPT
17	approved	approve	VBN	p2=VBD|pb=approve.01	13	ccomp	13:A1=PPT
18	and	and	CC	_	17	cc	_
19	cuts	cut	VBZ	p2=NNS|pb=cut.02	17	conj	_
20	$	$	$	_	22	quantmod	_
21	1.2	0	CD	_	22	number	_
22	billion	#crd#	CD	_	19	dobj	19:A1=PPT
23	from	from	IN	_	19	prep	19:A2=EXT
24	its	its	PRP$	_	25	poss	_
25	sales	sale	NNS	_	23	pobj	_
26	,	,	,	_	25	punct	_
27	general	general	JJ	_	25	amod	_
28	and	and	CC	_	27	cc	_
29	administrative	administrative	JJ	_	27	conj	_
30	expenses	expense	NNS	_	25	appos	_
31	-	-	,	p2=:	19	punct	_
32	the	the	DT	_	33	det	_
33	offer	offer	NN	_	19	dobj	35:A0
34	fully	fully	RB	_	35	advmod	35:AM-MNR
35	values	value	VBZ	pb=value.01	33	rcmod	_
36	the	the	DT	_	37	det	_
37	company	company	NN	_	35	dobj	35:A1
38	.	.	.	_	2	punct	_

1	Nonetheless	nonetheless	RB	_	4	advmod	4:AM-DIS
2	,	,	,	_	4	punct	_
3	Schoenebaum	schoenebaum	NNP	_	4	nsubj	4:A0=PAG
4	wrote	write	VBD	pb=write.01	0	root	_
5	that	that	IN	_	9	complm	_
6	Pfizer	pfizer	NNP	_	9	nsubj	9:A0=PAG
7	"	"	``	p2=''	9	punct	_
8	certainly	certainly	RB	_	9	advmod	9:AM-ADV
9	has	have	VBZ	pb=have.03	4	ccomp	4:A1=PPT
10	the	the	DT	_	12	det	_
11	financial	financial	JJ	_	12	amod	_
12	ability	ability	NN	_	9	dobj	9:A1=PPT
13	to	to	TO	_	14	aux	_
14	raise	raise	VB	pb=raise.01	12	infmod	_
15	the	the	DT	_	16	det	_
16	price	price	NN	_	14	dobj	14:A1=PPT
17	10	0	CD	_	18	num	_
18	%	%	NN	_	14	npadvmod	14:A2=EXT
19	,	,	,	_	4	punct	_
20	"	"	''	_	4	punct	_
21	and	and	CC	_	4	cc	_
22	that	that	IN	_	32	mark	_
23	its	its	PRP$	_	24	poss	_
24	view	view	NN	_	32	nsubj	32:A1=PPT
25	of	of	IN	_	24	prep	_
26	AstraZeneca	astrazeneca	NNP	_	29	poss	_
27	's	's	POS	_	26	possessive	_
28	peak	peak	NN	_	29	nn	_
29	sales	sale	NNS	_	25	pobj	_
30	potential	potential	JJ	p2=NN	29	amod	_
31	might	might	MD	_	32	aux	32:AM-MOD
32	be	be	VB	pb=be.01	4	conj	_
33	higher	high	JJR	_	32	acomp	32:A2=PRD
34	than	than	IN	_	33	prep	_
35	consensus	consensus	NN	_	34	pobj	_
36	.	.	.	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nn	_
2	investors	investor	NNS	_	6	nsubj	_
3	,	,	,	_	6	punct	_
4	however	however	RB	_	6	advmod	6:AM-DIS
5	,	,	,	_	6	punct	_
6	seemed	seem	VBD	pb=seem.01	0	root	_
7	at	at	IN	_	8	advmod	_
8	least	least	JJS	_	11	advmod	_
9	a	a	DT	_	10	det	_
10	little	little	JJ	p2=RB	11	amod	_
11	relieved	relieved	JJ	p2=VBN	6	oprd	6:A1=PPT
12	that	that	IN	p2=WDT	19	complm	_
13	the	the	DT	_	15	det	_
14	drug	drug	NN	_	15	nn	_
15	giant	giant	NN	p2=JJ	19	nsubj	19:A0=PAG
16	likely	likely	RB	p2=JJ	19	advmod	19:AM-ADV
17	wo	wo	MD	_	19	aux	19:AM-MOD
18	n't	not	RB	_	19	neg	19:AM-NEG
19	spend	spend	VB	pb=spend.02	11	ccomp	_
20	the	the	DT	_	21	det	_
21	money	money	NN	_	19	dobj	19:A1=VSP
22	.	.	.	_	6	punct	_

1	Its	its	PRP$	_	2	poss	_
2	stock	stock	NN	_	3	nsubj	3:A1
3	rose	rise	VBD	pb=rise.01	0	root	_
4	less	less	JJR	_	6	amod	_
5	than	than	IN	_	6	quantmod	_
6	1	0	CD	_	7	num	_
7	%	%	NN	_	3	npadvmod	3:A2=EXT
8	Monday	monday	NNP	_	3	npadvmod	3:AM-TMP
9	to	to	IN	_	3	prep	3:A4=LOC
10	29.28	0	CD	_	9	pobj	_
11	.	.	.	_	3	punct	_

